Background: To examine the association between level and patterns of baseline intra-tumoural BRAFV600E proteins appearance and clinical outcome of melanoma sufferers treated with selective BRAF inhibitors. (median IRS 28 (range 5C30)) and homogeneous (78%). Appearance of mutated proteins BRAFV600E as assessed by intensity, % immunoreactive cells, or IRS didn’t correlate with RECIST response, TTBR, PFS… Continue reading Background: To examine the association between level and patterns of baseline